Abstract
Marion Camard, Samia Hendou, Marie Bitu, Christelliah Mouanga, Faroudy Boufassa, Salome Laurans, Jérome Le Chenadec, Léo Plaçais, Véronique Avettand-Fenoël, Laurence Meyer, Christine Bourgeois, Emmanuelle Corruble, Olivier Lambotte, Romain Colle, Nicolas Noel
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global systematic review of common mental health disorders in adults living with HIV
10.1007/s11904-021-00583-w · 2021
Global prevalence of depressive symptoms among people living with HIV/AIDS: a systematic review and meta-analysis of the past five years
10.1080/09540121.2023.2285733 · 2024
The risk of mental illness in people living with HIV in the UK: a propensity score-matched cohort study
10.1016/s2352-3018(21)00319-2 · 2022
Meta-analysis of the relationship between HIV infection and risk for depressive disorders
10.1176/appi.ajp.158.5.725 · 2001
Neuroinflammation in HIV-associated depression: evidence and future perspectives
10.1038/s41380-022-01619-2 · 2022
Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda
10.1186/s12865-017-0239-3 · 2018
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data
10.7326/m14-0293 · 2014
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999–2015
10.3851/imp3223 · 2018
Mental health, ART adherence, and viral suppression among adolescents and adults living with HIV in South Africa: a cohort study
10.1007/s10461-022-03916-x · 2023
Food insecurity and mental health outcomes among people with HIV in West Africa
10.1097/qad.0000000000004200 · 2025
A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population
10.1038/s41598-022-10263-3 · 2022
HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication
10.1086/433188 · 2005
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy
10.1016/j.immuni.2007.08.010 · 2007
A subset of extreme Human Immunodeficiency Virus (HIV) controllers is characterized by a small HIV blood reservoir and a weak T-cell activation level
10.1093/ofid/ofx064 · 2017
Dynamics in HIV-DNA levels over time in HIV controllers
10.1002/jia2.25221 · 2019
Antiretroviral therapy for HIV controllers: reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
10.1016/j.eclinm.2021.100963 · 2021
Risk of non-AIDS-defining events is lower in Antiretroviral Therapy (ART)-naive HIV controllers than in normal progressors on suppressive ART
10.1093/cid/ciae440 · 2025
Non-AIDS-defining events in human immunodeficiency virus controllers versus antiretroviral therapy-controlled patients: a cohort collaboration from the French national agency for research on AIDS CO21 (CODEX) and CO06 (PRIMO) cohorts
10.1093/ofid/ofad067 · 2023
Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. military HIV natural history study
10.7448/ias.19.1.20524 · 2016
Analysis of non-AIDS-defining events in HIV controllers
10.1093/cid/ciw120 · 2016
Hospitalization rates and reasons among HIV elite controllers and persons with medically controlled HIV infection
10.1093/infdis/jiu809 · 2015
Identity, representations, and beliefs: HIV controllers living on the frontier of good health and illness
10.1177/1049732315617739 · 2016
Does quality of life and sexual quality of life in HIV patients differ between non-treated HIV controllers and treated patients in the French ANRS VESPA 2 national survey?
10.1007/s10461-018-2237-8 · 2019
Immunologic and virologic progression in HIV controllers: the role of viral “Blips” and immune activation in the ANRS CO21 CODEX study
10.1371/journal.pone.0131922 · 2015
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
1998
10.13140/rg.2.1.2792.9440
10.13140/rg.2.1.2792.9440
SCL-90: an outpatient psychiatric rating scale–preliminary report
1973
Unresolved referenced work
2015
Prevalence of psychological distress among people living with HIV/AIDS: a systematic review and meta-analysis
10.1080/09540121.2022.2080802 · 2023
Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States
10.1001/jamapsychiatry.2017.4602 · 2018
Factors leading to the loss of natural elite control of HIV-1 infection
10.1128/jvi.01805-17 · 2018
Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: a systematic review and meta-analysis
10.1371/journal.pone.0181960 · 2017
Metabolic consequences of antiretroviral therapy
10.1007/s11904-022-00600-6 · 2022
Depression and apathy among people living with HIV: implications for treatment of HIV associated neurocognitive disorders
10.1007/s10461-014-0970-1 · 2015
Association of syndemic unhealthy alcohol use, smoking, and depressive symptoms on incident cardiovascular disease among veterans with and without HIV-infection
10.1007/s10461-021-03327-4 · 2021
Food insecurity, internalized stigma, and depressive symptoms among women living with HIV in the United States
10.1007/s10461-018-2164-8 · 2018
Mental health and HIV/AIDS: the need for an integrated response
10.1097/qad.0000000000002227 · 2019
Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients
10.1097/qad.0000000000000174 · 2014
Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease
10.1016/j.bbi.2020.09.012 · 2020
Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms
10.1038/s41398-023-02489-0 · 2023
Major revision version 12.0 of the European AIDS clinical society guidelines 2023
10.1111/hiv.13542 · doi-reference
Primary care guidance for providers who care for persons with human immunodeficiency virus: 2024 update by the HIV medicine association of the Infectious Diseases Society of America
10.1093/cid/ciae479 · doi-reference
Higher soluble CD163 in blood is associated with significant depression symptoms in men with HIV
10.1097/qai.0000000000003063 · doi-reference